SCHEMBL6566840

SCHEMBL6566840

COc1ccc(NC(=O)Nc2ccc(OC(c3ccccc3)c3ccccc3)c(C(C)=O)c2)cc1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TP53 P04637 3/20 0.51
TSHR P16473 1/20 0.51
RAB9A P51151 6/20 0.50
NPC1 O15118 6/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
CASR P41180 1/20 0.50
MEN1 O00255 5/20 0.49
KMT2A Q03164 5/20 0.49
MAPT P10636 4/20 0.49
KDM4E B2RXH2 1/20 0.47
ALDH1A1 P00352 1/20 0.47
HIF1A Q16665 2/20 0.47
HTT P42858 1/20 0.47
SAE1 Q9UBE0 1/20 0.47
UBA2 Q9UBT2 1/20 0.47
IGF1R P08069 1/20 0.47
PKM P14618 1/20 0.46
GAA P10253 1/20 0.46
MAPK1 P28482 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6565806 0.92 TP53 (0.52) TP53TSHRRAB9ANPC1SMN1; SMN2
SCHEMBL6564596 0.91 TSHR (0.55) TP53TSHRRAB9ANPC1SMN1; SMN2
SCHEMBL6568011 0.91 KDM4E (0.54) TP53TSHRRAB9ANPC1SMN1; SMN2
SCHEMBL6567575 0.90 KMT2A (0.54) TP53RAB9ANPC1SMN1; SMN2MEN1
SCHEMBL6568152 0.89 RAB9A (0.48) TP53TSHRRAB9ANPC1SMN1; SMN2
SCHEMBL6564383 0.88 CASR (0.50) TP53TSHRRAB9ANPC1SMN1; SMN2
SCHEMBL6566646 0.86 SNCA (0.52) TP53TSHRRAB9ANPC1SMN1; SMN2
SCHEMBL6566652 0.86 SNCA (0.52) TP53TSHRRAB9ANPC1SMN1; SMN2
SCHEMBL6564615 0.86 TP53 (0.46) TP53TSHRRAB9ANPC1SMN1; SMN2
SCHEMBL6564786 0.83 KMT2A (0.61) RAB9ANPC1SMN1; SMN2CASRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-12-23 US disclosed
EP-1437344-A1 BENZENE DERIVATIVES,PROCESS FOR PREPARING THE SAME AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2004-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof HRH4, HRH2, HRH1 TP53 4453/4885TSHR 1061/4885RAB9A 1322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.